Insider trade

Opko Health (OPK): CEO bought ~$220K

FROST PHILLIP MD ET AL, CEO at Opko Health, bought ~$220K of Opko Health shares.

~$220K
Approx. value · 150K sh @ $1.47
213M
Holds after · shares reported
Traded
Jan 17, 2025
Filed
Jan 17, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 8, 2024InsiderCEO purchased ~$422K of OPK shares in the open market
  2. Nov 22, 2024InsiderCEO purchased ~$159K of OPK shares in the open market
  3. Nov 29, 2024InsiderCEO purchased ~$305K of OPK shares in the open market
  4. Dec 11, 2024InsiderCEO purchased ~$781K of OPK shares in the open market
  5. Dec 13, 2024InsiderCEO purchased ~$199K of OPK shares in the open market
  6. Jan 15, 2025InsiderCEO purchased ~$741K of OPK shares in the open market
  7. Jan 17, 2025 · this disclosureInsiderCEO purchased ~$220K of OPK shares in the open market

What came next

  1. Jan 28, 2025InsiderCEO purchased ~$70K of OPK shares in the open market
  2. Feb 28, 2025InsiderCEO purchased ~$115K of OPK shares in the open market
  3. Mar 17, 2025InsiderCEO purchased ~$348K of OPK shares in the open market
  4. Mar 28, 2025InsiderCEO purchased ~$254K of OPK shares in the open market
  5. Apr 1, 2025InsiderCEO purchased ~$165K of OPK shares in the open market
  6. Apr 8, 2025InsiderCEO purchased ~$185K of OPK shares in the open market
  7. Apr 10, 2025InsiderCEO purchased ~$170K of OPK shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Opko Health

For Opko Health, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OPK page.

Other recent filings by FROST PHILLIP MD ET AL, CEO & Chairman

The full history of FROST PHILLIP MD ET AL, CEO & Chairman is on the profile page.

How this filing works

Explore the data

Common questions

Which Opko Health (OPK) insider traded, and how much?

FROST PHILLIP MD ET AL, CEO at Opko Health, bought ~$220K of Opko Health shares. 150K shares at $1.47, open market.

When did it happen, and when was it made public?

Traded: Jan 17, 2025. Filed: Jan 17, 2025.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Opko Health recently?

For Opko Health, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the OPK page.

Does this mean OPK stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Opko Health

Everything OQRO holds on this company is on its OPK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data